Thermo Fisher Scientific Comprehensive Income 2010-2024 | TMO

Thermo Fisher Scientific comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Thermo Fisher Scientific comprehensive income for the quarter ending September 30, 2024 was $-2.477B, a 18.17% decline year-over-year.
  • Thermo Fisher Scientific comprehensive income for 2023 was $-3.224B, a 4.03% increase from 2022.
  • Thermo Fisher Scientific comprehensive income for 2022 was $-3.099B, a 33.06% increase from 2021.
  • Thermo Fisher Scientific comprehensive income for 2021 was $-2.329B, a 17.03% decline from 2020.
Thermo Fisher Scientific Annual Comprehensive Income
(Millions of US $)
2023 $-3,224
2022 $-3,099
2021 $-2,329
2020 $-2,807
2019 $-2,679
2018 $-2,498
2017 $-2,003
2016 $-2,636
2015 $-1,997
2014 $-1,285
2013 $-77
2012 $-150
2011 $-400
2010 $44
2009 $92
Thermo Fisher Scientific Quarterly Comprehensive Income
(Millions of US $)
2024-09-30 $-2,477
2024-06-30 $-2,413
2024-03-31 $-2,764
2023-12-31 $-3,224
2023-09-30 $-3,027
2023-06-30 $-2,924
2023-03-31 $-3,054
2022-12-31 $-3,099
2022-09-30 $-2,928
2022-06-30 $-2,724
2022-03-31 $-2,343
2021-12-31 $-2,329
2021-09-30 $-2,654
2021-06-30 $-2,630
2021-03-31 $-2,562
2020-12-31 $-2,807
2020-09-30 $-2,970
2020-06-30 $-2,989
2020-03-31 $-3,088
2019-12-31 $-2,679
2019-09-30 $-2,722
2019-06-30 $-2,630
2019-03-31 $-2,509
2018-12-31 $-2,498
2018-09-30 $-2,519
2018-06-30 $-2,491
2018-03-31 $-2,042
2017-12-31 $-2,003
2017-09-30 $-2,183
2017-06-30 $-2,256
2017-03-31 $-2,474
2016-12-31 $-2,636
2016-09-30 $-2,155
2016-06-30 $-2,082
2016-03-31 $-1,867
2015-12-31 $-1,997
2015-09-30 $-1,886
2015-06-30 $-1,595
2015-03-31 $-1,847
2014-12-31 $-1,285
2014-09-30 $-724
2014-06-30 $-112
2014-03-31 $-63
2013-12-31 $-77
2013-09-30 $-150
2013-06-30 $-456
2013-03-31 $-329
2012-12-31 $-150
2012-09-30 $-200
2012-06-30 $-458
2012-03-31 $-151
2011-12-31 $-400
2011-09-30 $-279
2011-06-30 $266
2011-03-31 $164
2010-12-31 $44
2010-09-30 $79
2010-06-30 $-150
2010-03-31 $-47
2009-12-31 $92
2009-09-30 $79
2009-06-30 $4
2009-03-31 $-258
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $197.408B $42.857B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $196.120B 102.54
Alcon (ALC) Switzerland $42.207B 28.24
Edwards Lifesciences (EW) United States $41.510B 26.36
IQVIA Holdings (IQV) United States $35.864B 19.76
IDEXX Laboratories (IDXX) United States $34.273B 40.36
DexCom (DXCM) United States $29.084B 43.80
Waters (WAT) United States $21.880B 32.35
STERIS (STE) Ireland $21.298B 24.52
SONOVA HOLDING (SONVY) Switzerland $20.458B 0.00
Hologic (HOLX) United States $18.284B 19.29
Fresenius Medical Care AG KGaA (FMS) Germany $12.898B 13.24
Sysmex ADR (SSMXY) Japan $12.776B 40.07
Globus Medical (GMED) United States $11.562B 29.28
Penumbra (PEN) United States $9.230B 90.41
Masimo (MASI) United States $9.055B 43.81
Teleflex (TFX) United States $8.854B 14.12
Glaukos (GKOS) United States $7.765B 0.00
PROCEPT BioRobotics (PRCT) United States $4.929B 0.00
Integer Holdings (ITGR) United States $4.558B 25.83
Veracyte (VCYT) United States $3.018B 90.56
Inari Medical (NARI) United States $2.913B 0.00
LivaNova (LIVN) United Kingdom $2.807B 16.21
TransMedics (TMDX) United States $2.663B 84.40
Nihon Kohden (NHNKY) Japan $2.428B 18.44
Elekta AB (EKTAY) Sweden $2.125B 17.31
Tandem Diabetes Care (TNDM) United States $2.019B 0.00
RxSight (RXST) United States $1.816B 0.00
Integra LifeSciences Holdings (IART) United States $1.775B 9.27
Alphatec Holdings (ATEC) United States $1.448B 0.00
Artivion (AORT) United States $1.175B 77.86
OPKO Health (OPK) United States $1.065B 0.00
Pulse Biosciences (PLSE) United States $0.992B 0.00
Paragon 28 (FNA) United States $0.873B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.828B 14.08
ORTHOFIX MEDICAL INC (OFIX) United States $0.714B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.641B 0.00
AxoGen (AXGN) United States $0.577B 0.00
Mesa Laboratories (MLAB) United States $0.548B 12.91
SiBone (SIBN) United States $0.515B 0.00
Treace Medical Concepts (TMCI) United States $0.495B 0.00
Pacific Biosciences Of California (PACB) United States $0.485B 0.00
Semler Scientific (SMLR) United States $0.483B 32.40
Tactile Systems Technology (TCMD) United States $0.383B 20.70
CVRx (CVRX) United States $0.358B 0.00
Delcath Systems (DCTH) United States $0.315B 0.00
ClearPoint Neuro (CLPT) United States $0.306B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
NeuroPace (NPCE) United States $0.269B 0.00
Inogen (INGN) United States $0.219B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.190B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Nevro (NVRO) United States $0.163B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.150B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.67
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.087B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Covalon Technologies (CVALF) Canada $0.077B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
Vicarious Surgical (RBOT) United States $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
Neuronetics (STIM) United States $0.025B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00